Identification of causal plasma metabolite biomarkers for ischemic stroke using Mendelian randomization and mediation analysis
Open Access
- 14 May 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Abstract
The Global Burden of Disease Study 2021 reports that stroke remains a leading cause of death, with ischemic stroke (IS) presenting significant challenges in screening, prevention, and treatment. We explored the causal effects of 1,400 plasma metabolites on IS outcomes using a two-sample Mendelian randomization (MR) framework. We assessed causal relationships between IS and 11 common clinical risk factors and further examined these relationships for metabolites. Mediation analysis identified mechanisms for metabolites affecting both IS and its risk factors. Finally, a phenome-wide association study (PheWAS) MR analysis evaluated the side effects and additional indications of IS-associated metabolites across 3,948 phenotypes from the UKBB GWAS. Nineteen metabolites showed a causal relationship with IS. MR analysis confirmed body mass index (BMI), high-density lipoprotein (HDL), systolic blood pressure (SBP), diastolic blood pressure (DBP), and type 2 diabetes (T2D) as risk factors for IS. Among 136 metabolites associated with at least one IS risk factor, 132 were linked to risk factors but not directly to IS. BMI, DBP, and coffee intake mediated the causal relationship between IS and the levels of 1-stearoyl-GPG (18:0), 1-oleoyl-2-linoleoyl-GPE (18:1/18:2), Octadecadienedioate (C18:2-DC), and X-24,951. Phe-MR analysis indicated that these metabolites were protective and affected other indications similarly to IS. Our findings reveal causal pathways and identify four potential biomarkers for IS, providing new insights for its screening, prevention, and treatment.Keywords
Funding Information
- National Natural Science Foundation of China (82205101)
- National Key Research and Development Program of China (2018YFC1707400)
This publication has 56 references indexed in Scilit:
- HDL cholesterol efflux capacity and phospholipid content are associated with the severity of acute ischemic stroke and predict its outcomeClinica Chimica Acta, 2023
- Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian RandomizationJAMA, 2021
- Application of Metabolomics to the Discovery of Biomarkers for Ischemic Stroke in the Murine Model: a Comparison with the Clinical ResultsMolecular Neurobiology, 2021
- Mendelian randomisation for mediation analysis: current methods and challenges for implementationEuropean Journal of Epidemiology, 2021
- Probabilistic colocalization of genetic variants from complex and molecular traits: promise and limitationsThe American Journal of Human Genetics, 2021
- Increased Stroke Risk in Metabolically Abnormal Normal Weight: a 10-Year Follow-up of 102,037 Participants in ChinaTranslational Stroke Research, 2020
- Prevalence and risk factors of stroke in the elderly in Northern China: data from the National Stroke Screening SurveyJournal of Neurology, 2019
- Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of ChinaJAMA, 2017
- Phosphatidylethanolamine Metabolism in Health and Disease2016
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009